ASX-Dividend-Report-Banner

MGI Named a Finalist in the 2024 Edison Awards™ for Innovative DNBSEQ-T20x2* Gene Sequencer

February 09, 2024 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 MGI Named a Finalist in the 2024 Edison Awards™ for Innovative DNBSEQ-T20x2* Gene Sequencer
Image source: Kalkine Media

SHENZHEN, China, Feb. 8, 2024 /PRNewswire/ -- MGI Tech, a company committed to building core tools and technology to lead life science, today announced its nomination as a finalist for the 2024 Edison Awards™ in the "Health, Medical & Biotech" category for the outstanding innovation and distinguished impact of its DNBSEQ-T20x2* gene sequencer.

Established in 1987, the Edison Awards™ is as one of the oldest and most esteemed technology honors globally. Named after the American inventor Thomas Edison and known as "the Oscars of tech," this prestigious event has previously recognized the achievements of luminaries, such as General Motors, SpaceX, LG Electronics USA and Logitech, for their exceptional contribution to service development and innovation.

All nominations are reviewed by the Edison Awards Steering Committee and a Panel of Judges. The panel is comprised of more than 3,000 industry experts, senior business executives and academics from the fields of product development, design, engineering, science, marketing, and education, as well as past winners. The "Health, Medical & Biotech" category, in particular, honors products and services that have made a profound impact on patients and healthcare providers.

MGI's revolutionary DNBSEQ-T20x2* ultra-high-throughput sequencer has been in the limelight since its launch in February 2023 for successfully lowering genome sequencing costs to below $100 per genome. This breakthrough enables sequencing of a greater number of samples, or a more in-depth, informative, and accurate analysis per sample.

The commercial success of DNBSEQ-T20x2* has not only elevated sequencing capabilities, but also propelled global scientific discoveries by doubling the efficiency of DNA sequencing. With its ultra-high throughput and excellent cost-efficiency, the sequencer is contributing to the development of the global genetic industry and driving progress in understanding the human genome and medical applications.

Following its launch, DNBSEQ-T20×2* has gained widespread adoption among globally leading research institutions and healthcare providers, including corporate orders by Shanghai-based JMDNA Biomedical Technology Co., Ltd and Prepaire Labs, a healthcare technology company in Abu Dhabi. DNBSEQ-T20×2* has also garnered numerous awards, including the 2023 R&D 100 Awards, BEYOND Healthcare Innovation Award, 2023 BioTech Breakthrough Awards, and 2023 Globee® Awards, for its cutting-edge innovation.  

The Edison Awards™ Gala is scheduled to take place on April 18 in Fort Myers, Florida, where results will be announced.

About MGI
MGI Tech Co. Ltd. (or its subsidiaries, together referred to MGI), headquartered in Shenzhen, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers*, and its multi-omics platforms include genetic sequencing*, medical imaging, and laboratory automation. MGI's mission is to develop and promote advanced life science tools for future healthcare. For more information, please visit the MGI website or connect with us on TwitterLinkedIn or YouTube.
*For Research Use Only. Not for use in diagnostic procedures.

About Edison Awards
Established in 1987, the Edison Awards are dedicated to recognizing, honoring and fostering innovations and innovators. Named after Thomas Alva Edison (1847-1931), the annual competition honors excellence in new product and service development, marketing, design and innovation. Past award recipients include Steve Jobs, Elon Musk, and leaders of global corporations such as Coca-Cola, Genentech, General Electric, General Motors, IBM and Campbell Soup Co. In 2021, the Edison Awards introduced the inaugural Lewis Latimer Fellowship program designed to celebrate, connect and bring together a community of innovative Black thought leaders. For more information, visit www.edisonawards.com.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.